Home - Products - GPCR/G Protein - Calcium Channel - Lanthanum(III) chloride heptahydrate

Lanthanum(III) chloride heptahydrate

CAS No. 10025-84-0

Lanthanum(III) chloride heptahydrate( —— )

Catalog No. M27559 CAS No. 10025-84-0

Lanthanum(III) chloride is an inorganic compound which used in biochemical research to block the activity of divalent cation channels, especially calcium channels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
5MG 38 In Stock
10MG 54 In Stock
25MG 89 In Stock
50MG 128 In Stock
100MG 184 In Stock
200MG 276 In Stock
500MG 476 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lanthanum(III) chloride heptahydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Lanthanum(III) chloride is an inorganic compound which used in biochemical research to block the activity of divalent cation channels, especially calcium channels.
  • Description
    Lanthanum(III) chloride is an inorganic compound which used in biochemical research to block the activity of divalent cation channels, especially calcium channels.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    10025-84-0
  • Formula Weight
    371.36
  • Molecular Formula
    Cl3H14LaO7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O.O.O.O.O.O.O.Cl[La](Cl)Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abu-Baker S, et al. Cytotoxicity and Selectivity in Skin Cancer by SapC-DOPS Nanovesicles. J Cancer Ther. 2012 Aug;3(4):321-326.
molnova catalog
related products
  • Opc 8490

    Opc 8490 is a cardiotonic agent and a positive inotropic vasodilator that increases Ca current (ICa) in a dose-dependent and reversible manner and prolongs atrial action potential in a concentration-dependent manner.

  • Zonisamide

    Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures.

  • MMK 1

    Potent and selective human formyl peptide receptor FPR2 agonist (EC50 values are 1, 2 and > 10 000 nM at mFRP2, hFPR2 and hFPR1 respectively). Induces migration of human monocytes and neutrophils via a chemotactic mechanism and enhances production of proinflammatory cytokines IL-1β and IL-6. Also activates the neutrophil superoxide-generating NADPH-oxidase.